Commentary

Journal of Investigative Dermatology (2007) 127, 2709–2710. doi:10.1038/sj.jid.5701129

Chronic Medication Use and Inflammatory Skin Diseases: The Power and Limitations of the Case–Control Study

Robert S Stern1

1Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

Correspondence: Dr Robert S Stern, Department of Dermatology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, GZ522, Boston, Massachusetts 02215, USA. E-mail: rstern@bidmc.harvard.edu

Top

Abstract

The potential of newly introduced medications to cause acute inflammatory skin diseases has long been recognized. Less well accepted and not often systematically studied is the role of long-term drug use in inflammatory skin diseases such as eczema. Hypothesis-driven case–control studies provide what is probably the most efficient but far from easy method to evaluate and quantify observations from case reports and case series that suggest a drug etiology for chronic skin diseases.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

How pre-B cells know when they have it right

Nature Immunology News and Views (01 Sep 2003)

Extra navigation

.
ADVERTISEMENT